Differential Modulation of Glutamate Transporter‐1 by Cocaine and Oxycodone and the Efficacy of MC‐100093 to Reduce Reinstatement of Self‐Administration
Brain and Behavior · 2025
DOI: 10.1002/brb3.70616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Damyan W Hart und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Oxycodone, Cocaine, Excitatory Amino Acid Transporter 2, Drug-Seeking Behavior. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Introduction
Despite the widespread impact of opioid use disorder, pharmacological options for treatment remain limited. Recent studies find that cocaine exposure decreases the expression of the glutamate transporter GLT‐1 in the nucleus accumbens (NAc) and that treatment with the beta‐lactam antibiotic ceftriaxone rescues this loss of expression and reduces cue‐induced reinstatement to cocaine self‐administration. The novel beta‐lactam derivative MC‐100093 (093) lacks antimicrobial properties but crosses the blood‐brain barrier more rapidly and retains the beneficial effects of ceftriaxone following cocaine. However, 093 effects following oxycodone exposure have not been examined.
Methods
We used intravenous self‐administration (IVSA) of oxycodone in rats to test if 093 can attenuate oxycodone seeking. Membrane expression of GLT‐1 in the NAc was investigated using western blots. Conditioned place preference (CPP) was used to test the effect of oxycodone and cocaine alone on GLT‐1 expression.
Results
We find that 093 injections following IVSA of oxycodone in rats did not reduce cue‐induced reinstatement. Interestingly, western blot analysis revealed that 093 failed to upregulate the expression of GLT‐1 in the NAc of oxycodone‐exposed animals. Follow‐up CPP experiments suggest that oxycodone exposure alone does not decrease GLT‐1 expression as cocaine does.
Conclusions
Our results indicate that drug‐specific reductions in NAc GLT‐1 expression may be necessary for 093's efficacy. Further investigation into 093 and other opioids is needed to fully understand their relationship with GLT‐1 expression and beta‐lactams.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA.
- Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, Minnesota, USA.
- Graduate Program in Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA.
- School of Pharmacy, Temple University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Mark J Thomas
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Hart, D. W., Alonso-Caraballo, Y., Hornback, B., Robert, A., Brickner, M. A., Esguerra, M., Childers, W. E., Abou-Gharbia, M., & Thomas, M. J. (2025). Differential Modulation of Glutamate Transporter‐1 by Cocaine and Oxycodone and the Efficacy of MC‐100093 to Reduce Reinstatement of Self‐Administration. Brain and Behavior. https://doi.org/10.1002/brb3.70616
Vancouver
Hart DW, Alonso-Caraballo Y, Hornback B, Robert A, Brickner MA, Esguerra M, et al. Differential Modulation of Glutamate Transporter‐1 by Cocaine and Oxycodone and the Efficacy of MC‐100093 to Reduce Reinstatement of Self‐Administration. Brain and Behavior. 2025. doi:10.1002/brb3.70616
BibTeX
@article{Hart2025,
author = {Hart, Damyan W and Alonso-Caraballo, Yanaira and Hornback, Britta and Robert, Angel and Brickner, Megan A and Esguerra, Manuel and Childers, Wayne E and Abou-Gharbia, Magid and Thomas, Mark J},
title = {Differential Modulation of Glutamate Transporter‐1 by Cocaine and Oxycodone and the Efficacy of MC‐100093 to Reduce Reinstatement of Self‐Administration},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70616}
}
EUVIMED